Gates Package — page 197

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl 2013-0810 CRADA 7/5/2016] 7/5/2028) Sanofi US Services Inc. Ursula Buchholz Malaria Research and Training Center at the Universite de Bamako (University of, Sanaria, Inc. 2013-0836 CTA - Clinical Trial Agreement 1/17/2014| (see also Protein Potential) Sara Healy Malaria Research and Training Center at the Universite de Bamako (University of, Sanaria, Inc. 2013-0836 CTA - Clinical Trial Agreement 1/17/2014 (see also Protein Potential) Sara Healy Malaria Research and Training Center at the Universite de Bamako (University of, Sanaria, Inc. 2013-0836 CTA - Clinical Trial Agreement 1/17/2014 (see also Protein Potential) Sara Healy 2013-0871 Research Collaboration Agreement 6/26/2014] 6/26/2016|Genocea Biosciences, Inc. Peter Crompton 2013-0874 CRADA 1/4/2016] 1/27/2017|EMD Serono Research & Development Institute Roshanak Semnan| 2013-0874 CRADA 1/4/2016] 1/27/2017|EMD Serono Research & Development Institute Roshanak Semnan| University of Sao Paulo (Universidade de Sado Paulo) 2013-0943 Research Collaboration Agreement 9/4/2013 9/5/2018} (USP) [BR] Jose Ribeiro GlaxoSmithKline PLC (formerly Glaxo Wellcome 2013-1017 CTA - Clinical Trial Agreement 6/24/2014| PLC) (GSK) [GB] Amy Klion GlaxoSmithKline PLC (formerly Glaxo Wellcome 2013-1017 CTA - Clinical Trial Agreement 6/24/2014 PLC) (GSK) [GB] Amy Klion 2013-1084 Research Collaboration Agreement 4/18/2014 DNA 2.0 Stephen Leppla 2013-1107 Research Collaboration Agreement 2/9/2015] 2/10/2017]J. Craig Venter Institute Bernard Moss 2013-1112 Gift 11/13/2015] 8/31/2017] University of South Florida 2013-1112 Gift 11/13/2015} --8/31/2017| University of South Florida 2013-1156 Research Collaboration Agreement 2/28/2014] _2/28/2018]University of North Carolina at Chapel Hill Edward Berger Crucell Holland, B.V. (acq by Johnson & Johnson in 2011; J&J; Janssen Research a, Fred Hutchinson 2013-1175 Letter of Intent/MOU 3/13/2023} 5/2/2026] Cancer Research Center (FHCRC) [US] Mary Marovich Crucell Vaccines Institute (part of Johnson & 2013-1217 CRADA 11/13/2013} _7/23/2020|Johnson; J&J) Jeffery Taubenber Crucell Vaccines Institute (part of Johnson & Johnson; J&J), Janssen Vaccines & Prevention B.V. 2013-1217 CRADA 11/13/2013} 7/23/2020] (part of Johnson & Johnson; J&J) [NL] Jeffery Taubenber Crucell Vaccines Institute (part of Johnson & 2013-1217 CRADA 11/13/2013] 7/23/2020|Johnson; J&J) Jeffery Taubenber